1. Home
  2. PCVX vs NAKA Comparison

PCVX vs NAKA Comparison

Compare PCVX & NAKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$46.76

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Kindly MD Inc. Common Stock

NAKA

Kindly MD Inc. Common Stock

HOLD

Current Price

$0.51

Market Cap

347.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCVX
NAKA
Founded
2013
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
347.4M
IPO Year
2020
2024

Fundamental Metrics

Financial Performance
Metric
PCVX
NAKA
Price
$46.76
$0.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
2
Target Price
$101.67
$4.50
AVG Volume (30 Days)
1.5M
14.1M
Earning Date
11-04-2025
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,980,278.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2,774.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.66
$0.43
52 Week High
$94.60
$34.77

Technical Indicators

Market Signals
Indicator
PCVX
NAKA
Relative Strength Index (RSI) 51.97 35.16
Support Level $43.78 $0.47
Resistance Level $48.11 $0.56
Average True Range (ATR) 1.99 0.05
MACD -0.49 0.05
Stochastic Oscillator 42.99 46.03

Price Performance

Historical Comparison
PCVX
NAKA

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About NAKA Kindly MD Inc. Common Stock

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

Share on Social Networks: